FOLD
Price
$6.09
Change
-$0.00 (-0.00%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
1.87B
83 days until earnings call
FOR
Price
$19.98
Change
+$0.42 (+2.15%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
1.99B
74 days until earnings call
Ad is loading...

FOLD vs FOR

Header iconFOLD vs FOR Comparison
Open Charts FOLD vs FORBanner chart's image
Amicus Therapeutics
Price$6.09
Change-$0.00 (-0.00%)
Volume$228.28K
Capitalization1.87B
Forestar Group
Price$19.98
Change+$0.42 (+2.15%)
Volume$1.4K
Capitalization1.99B
FOLD vs FOR Comparison Chart
Loading...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FOLD vs. FOR commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOLD is a Hold and FOR is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (FOLD: $6.09 vs. FOR: $19.99)
Brand notoriety: FOLD and FOR are both not notable
FOLD represents the Biotechnology, while FOR is part of the Real Estate Development industry
Current volume relative to the 65-day Moving Average: FOLD: 152% vs. FOR: 60%
Market capitalization -- FOLD: $1.87B vs. FOR: $1.99B
FOLD [@Biotechnology] is valued at $1.87B. FOR’s [@Real Estate Development] market capitalization is $1.99B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The market cap for tickers in the [@Real Estate Development] industry ranges from $165.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B. The average market capitalization across the [@Real Estate Development] industry is $5.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FOLD’s FA Score shows that 0 FA rating(s) are green whileFOR’s FA Score has 0 green FA rating(s).

  • FOLD’s FA Score: 0 green, 5 red.
  • FOR’s FA Score: 0 green, 5 red.
According to our system of comparison, FOR is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FOLD’s TA Score shows that 4 TA indicator(s) are bullish while FOR’s TA Score has 5 bullish TA indicator(s).

  • FOLD’s TA Score: 4 bullish, 4 bearish.
  • FOR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, FOR is a better buy in the short-term than FOLD.

Price Growth

FOLD (@Biotechnology) experienced а -20.70% price change this week, while FOR (@Real Estate Development) price change was +3.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.88%. For the same industry, the average monthly price growth was +15.29%, and the average quarterly price growth was -13.75%.

The average weekly price growth across all stocks in the @Real Estate Development industry was +1.52%. For the same industry, the average monthly price growth was +5.21%, and the average quarterly price growth was -5.40%.

Reported Earning Dates

FOLD is expected to report earnings on Jul 31, 2025.

FOR is expected to report earnings on Jul 22, 2025.

Industries' Descriptions

@Biotechnology (-3.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Real Estate Development (+1.52% weekly)

Activities range from the renovation and re-lease of existing buildings to the purchase of raw land and the sale of developed land or parcels to others. Demand for land development business is driven by GDP growth, employment rates, interest rates, and access to/cost of capital. For individual companies in this industry, proper cost estimation and successful bidding play critical roles in their profitability. Large companies could potentially have greater access to capital, while smaller companies can specialize in a specific geographic area or market niche. CBRE Group, VICI Properties Inc and Brookfield Property Partners L.P. are some of the large companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FOR($1.99B) has a higher market cap than FOLD($1.87B). FOR YTD gains are higher at: -22.878 vs. FOLD (-35.350). FOR has higher annual earnings (EBITDA): 230M vs. FOLD (29.4M). FOR has more cash in the bank: 459M vs. FOLD (250M). FOLD has less debt than FOR: FOLD (444M) vs FOR (714M). FOR has higher revenues than FOLD: FOR (1.53B) vs FOLD (528M).
FOLDFORFOLD / FOR
Capitalization1.87B1.99B94%
EBITDA29.4M230M13%
Gain YTD-35.350-22.878155%
P/E RatioN/A10.84-
Revenue528M1.53B35%
Total Cash250M459M54%
Total Debt444M714M62%
FUNDAMENTALS RATINGS
FOLD vs FOR: Fundamental Ratings
FOLD
FOR
OUTLOOK RATING
1..100
1155
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
10070
SMR RATING
1..100
9365
PRICE GROWTH RATING
1..100
9185
P/E GROWTH RATING
1..100
10083
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FOLD's Valuation (68) in the Biotechnology industry is in the same range as FOR (72) in the Real Estate Development industry. This means that FOLD’s stock grew similarly to FOR’s over the last 12 months.

FOR's Profit vs Risk Rating (70) in the Real Estate Development industry is in the same range as FOLD (100) in the Biotechnology industry. This means that FOR’s stock grew similarly to FOLD’s over the last 12 months.

FOR's SMR Rating (65) in the Real Estate Development industry is in the same range as FOLD (93) in the Biotechnology industry. This means that FOR’s stock grew similarly to FOLD’s over the last 12 months.

FOR's Price Growth Rating (85) in the Real Estate Development industry is in the same range as FOLD (91) in the Biotechnology industry. This means that FOR’s stock grew similarly to FOLD’s over the last 12 months.

FOR's P/E Growth Rating (83) in the Real Estate Development industry is in the same range as FOLD (100) in the Biotechnology industry. This means that FOR’s stock grew similarly to FOLD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FOLDFOR
RSI
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
44%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 9 days ago
70%
Bullish Trend 7 days ago
71%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 3 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
47%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IFTIX12.25N/A
N/A
Voya International High Div Low Vol I
FMAGX14.67N/A
N/A
Fidelity Magellan
SMECX8.10N/A
N/A
Invesco Small Cap Equity C
JANVX77.21N/A
N/A
Janus Henderson Venture D
TNYRX10.18N/A
N/A
1290 Loomis Sayles Multi-Asset Income R